Hallmark analysis indicated that MFSD12 upregulates interferon-γ response and inflammation, while downregulating Wnt/β-catenin signaling and androgen response, acting as both a promoter of immune pathways and a suppressor of cancer-related processes in the LIHC environment. The gene discussed is MFSD12; the disease is cancer.